Long, R., & Chen, F. First-line chemotherapy with tislelizumab for patients with extensive-stage small cell lung cancer: A cost-effectiveness analysis. Nature Portfolio.
Chicago Style (17th ed.) CitationLong, Rong, and Fangping Chen. First-line Chemotherapy with Tislelizumab for Patients with Extensive-stage Small Cell Lung Cancer: A Cost-effectiveness Analysis. Nature Portfolio.
MLA (9th ed.) CitationLong, Rong, and Fangping Chen. First-line Chemotherapy with Tislelizumab for Patients with Extensive-stage Small Cell Lung Cancer: A Cost-effectiveness Analysis. Nature Portfolio.
Warning: These citations may not always be 100% accurate.